The Wilmington-Clinton County Chamber of Commerce’s 2024 Annual Meeting, a hallmark event for local businesses and community ...

The market expects Alkermes (ALKS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is ...

Alkermes (ALKS) expects its set of proprietary products, Vivitrol, Aristada and Lybalvi, to generate incremental sales and ...

My name is Madison, and I will be your conference operator today. At this time, I would like to welcome everyone to Harmony ...

In a report released today, Alex Fuhrman from Craig-Hallum maintained a Buy rating on LifeMD (LFMD – Research Report). The ...

Six fast-growing startups have been selected to receive a $100,000 investment each and will participate in the 12-week ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alkermes (ALKS – Research Report) and Ocular ...

Alkermes plc (Nasdaq: ALKS) today announced initiation of the Vibrance-1 study, a phase 2 clinical trial evaluating the ...

The U.S. FDA approved ImmunityBio's combination therapy to treat a type of bladder cancer, the regulator said on Monday, which would help bring the company's first product to market.

Growing need for effective delivery of novel biopharmaceuticals and pharmaceutical coupled with innovation in drug delivery ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

US pharma major Bristol Myers Squibb has announced the investment of $400 million into a company facility in Dublin, Ireland. French pharma major Sanofi has announced that Rippon Ubhi has been ...